Cargando…
Seroprevalence of Infection-Induced SARS-CoV-2 Antibodies — United States, September 2021–February 2022
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Centers for Disease Control and Prevention
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098232/ https://www.ncbi.nlm.nih.gov/pubmed/35482574 http://dx.doi.org/10.15585/mmwr.mm7117e3 |
| _version_ | 1784706336421838848 |
|---|---|
| author | Clarke, Kristie E.N. Jones, Jefferson M. Deng, Yangyang Nycz, Elise Lee, Adam Iachan, Ronaldo Gundlapalli, Adi V. Hall, Aron J. MacNeil, Adam |
| author_facet | Clarke, Kristie E.N. Jones, Jefferson M. Deng, Yangyang Nycz, Elise Lee, Adam Iachan, Ronaldo Gundlapalli, Adi V. Hall, Aron J. MacNeil, Adam |
| author_sort | Clarke, Kristie E.N. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9098232 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Centers for Disease Control and Prevention |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90982322022-05-19 Seroprevalence of Infection-Induced SARS-CoV-2 Antibodies — United States, September 2021–February 2022 Clarke, Kristie E.N. Jones, Jefferson M. Deng, Yangyang Nycz, Elise Lee, Adam Iachan, Ronaldo Gundlapalli, Adi V. Hall, Aron J. MacNeil, Adam MMWR Morb Mortal Wkly Rep Full Report Centers for Disease Control and Prevention 2022-04-29 /pmc/articles/PMC9098232/ /pubmed/35482574 http://dx.doi.org/10.15585/mmwr.mm7117e3 Text en https://creativecommons.org/publicdomain/zero/1.0/All material in the MMWR Series is in the public domain and may be used and reprinted without permission; citation as to source, however, is appreciated. |
| spellingShingle | Full Report Clarke, Kristie E.N. Jones, Jefferson M. Deng, Yangyang Nycz, Elise Lee, Adam Iachan, Ronaldo Gundlapalli, Adi V. Hall, Aron J. MacNeil, Adam Seroprevalence of Infection-Induced SARS-CoV-2 Antibodies — United States, September 2021–February 2022 |
| title | Seroprevalence of Infection-Induced SARS-CoV-2 Antibodies — United States, September 2021–February 2022 |
| title_full | Seroprevalence of Infection-Induced SARS-CoV-2 Antibodies — United States, September 2021–February 2022 |
| title_fullStr | Seroprevalence of Infection-Induced SARS-CoV-2 Antibodies — United States, September 2021–February 2022 |
| title_full_unstemmed | Seroprevalence of Infection-Induced SARS-CoV-2 Antibodies — United States, September 2021–February 2022 |
| title_short | Seroprevalence of Infection-Induced SARS-CoV-2 Antibodies — United States, September 2021–February 2022 |
| title_sort | seroprevalence of infection-induced sars-cov-2 antibodies — united states, september 2021–february 2022 |
| topic | Full Report |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098232/ https://www.ncbi.nlm.nih.gov/pubmed/35482574 http://dx.doi.org/10.15585/mmwr.mm7117e3 |
| work_keys_str_mv | AT clarkekristieen seroprevalenceofinfectioninducedsarscov2antibodiesunitedstatesseptember2021february2022 AT jonesjeffersonm seroprevalenceofinfectioninducedsarscov2antibodiesunitedstatesseptember2021february2022 AT dengyangyang seroprevalenceofinfectioninducedsarscov2antibodiesunitedstatesseptember2021february2022 AT nyczelise seroprevalenceofinfectioninducedsarscov2antibodiesunitedstatesseptember2021february2022 AT leeadam seroprevalenceofinfectioninducedsarscov2antibodiesunitedstatesseptember2021february2022 AT iachanronaldo seroprevalenceofinfectioninducedsarscov2antibodiesunitedstatesseptember2021february2022 AT gundlapalliadiv seroprevalenceofinfectioninducedsarscov2antibodiesunitedstatesseptember2021february2022 AT hallaronj seroprevalenceofinfectioninducedsarscov2antibodiesunitedstatesseptember2021february2022 AT macneiladam seroprevalenceofinfectioninducedsarscov2antibodiesunitedstatesseptember2021february2022 |